The assay involves testing drugs that interfere with the RECQ1 protein, which is responsible for resolving abnormal DNA structures formed during replication or homologous recombination. The activity of RECQ1 Helicase DNA unwinding is measured using a fluorescence quenching based kinetic qHTS assay. The assay involves using a forked DNA substrate that is tagged with a rhodamine fluorophore and a dark quencher, which results in an increase in the fluorescence of the rhodamine upon ATP-dependent strand separation. The assay also includes the use of poly (dIdC) to reduce interference by compounds such as DNA intercalators, which can lead to false inhibitors. The goal of the assay is to identify drugs that sensitize cancer cells to radiation or chemotherapy by interfering with DNA repair mechanisms. Is the molecule effective to this assay?